-
Bayeux Tapestry to arrive in London after epic journey from France
-
H5 bird flu detected in Australian seabird for first time
-
Syria authorities say captured IS-linked cell behind blasts
-
Myanmar's pro-democracy revolution weakens five years on
-
Table for one: how Japan's 'Solitary Gourmet' became a TV hit
-
Hundreds flee homes in Taiwan ahead of biggest typhoon in decades
-
Australia's Big Bash League to open season in India
-
Asian stocks rally as SK hynix breathes life back into AI trade
-
Disappointment at Morocco's World Cup exit cannot mask pride
-
Humanitarians look to put the AI in aid
-
In gas-rich Kazakhstan, many rely on lethal cylinders
-
Indian haute couture presence 'overdue', says designer Manish Malhotra
-
Chip titan SK hynix raises $26.5 bn in blockbuster US listing
-
'Everyone' expects Spain to beat us, says Belgium coach
-
Venezuela quake tragedy threatens to set back democratic transition
-
France's Galthie says 'hot and cold' Australia still a threat
-
Yamal's best 'yet to come,' warns Spain coach
-
Mbappe warns 'a long way to go' for France at World Cup after reaching semis
-
'Up to him' - Curry on chance that LeBron lands with Warriors
-
Deschamps hails Mbappe after superstar fires France into World Cup semis
-
Revamped Ireland wary of 'bang in form' Japan
-
OpenAI number two Simo steps down to focus on health
-
Morocco coach Ouahbi vows team will come back stronger after World Cup exit
-
Iran buries Khamenei after new fighting with US erupts
-
Rennie says Italy won't catch All Blacks off guard
-
Can ageless Messi keep delivering for Argentina at World Cup?
-
McIlroy encouraged by 'great start' to Scottish Open
-
Chip titan SK hynix to raise $26.5 bn in blockbuster US listing
-
England chase World Cup glory as Haaland allows Norway to dream
-
Bayeux Tapestry begins epic journey from France to London
-
'When it's Kylian, there's no problem': Deschamps after France into semis
-
Mbappe, Dembele fire France past Morocco into World Cup semi-finals
-
Mbappe strikes again as France beat Morocco to reach World Cup semi-finals
-
Chip titan SK hynix readies for mega US listing
-
Sick Olympic champion McKeown pulls out of Commonwealth Games, PanPacs
-
Iyer says India in 'transition' after latest thrashing by England
-
Traeen out of Tour de France after losing yellow jersey
-
Iyer says India in 'transition' after latest England thrashing
-
Ukrainian sports minister slams IOC's 'cynical' Russia decision
-
Silencing World Cup hotshot Haaland vital, says England's O'Reilly
-
Leonard return to Raptors on hold pending Clippers probe
-
Australian sprint sensation Gout Gout set to miss rest of season
-
US pushes for weaker truck pollution rules
-
England thrash India by nine wickets for T20 series win
-
Black and cream and very Roman at Fendi haute couture show
-
Wimbledon run came 'out of nowhere', says finalist Noskova
-
Spain keeping opposition far from goal at World Cup, says 'keeper Garcia
-
India captain Kaur hopes Lord's Test can offset World Cup woes
-
Czech mates Muchova and Noskova to clash in Wimbledon final
-
China factory fire kills at least 28 people
Nitches, Inc. (OTC: NICH) Is Building the Checkpoint Every Supplement Brand Will Have to Pass Before It Spends a Dollar on Manufacturing
A new supplement readiness platform is coming. The company that formulated InTheZone is turning its capability outward, toward the founders, brands, and capital that need to know a product can survive scrutiny before the money moves.
LAS VEGAS, NV / ACCESS Newswire / June 11, 2026 / Nitches, Inc (OTCID:NICH) - Founders, creators, and brands interested in learning more about starting a supplement line can email [email protected] now for soft launch details and early access to the list.
Nitches, Inc. is preparing a new platform designed to help supplement founders and brands move from idea to product readiness with more clarity than the industry has ever offered them.
The thesis is direct. Most supplement ideas do not fail because the founder lacked ambition. They fail because the path from idea to formula, claims, label, manufacturing, packaging, and fulfillment is fragmented, and the costly surprises arrive after the capital is already committed. Nitches is building the checkpoint that comes before money moves.
What the Platform Does
The platform is being built to guide users through the early product-building process. It helps founders and brands:
Shape a supplement concept
Explore formulation direction
Review ingredient evidence
Understand claim and label readiness
Generate a product readiness score
Create a portable product record
Prepare for manufacturing review
Explore startup-friendly production pathways
Connect the idea-to-shelf process more intelligently
This is not just another supplement website. It is designed to become the checkpoint before money moves into manufacturing, branding, packaging, and launch.
The Foundation Beneath It
Nitches did not arrive at this from theory. The company formulated and brought to market InTheZone, and it is now turning that same capability into infrastructure for others.
The platform sits on top of real manufacturing readiness. Nitches works in alignment with an FDA-registered, cGMP-aligned manufacturing partner, a fully integrated producer of fine, all-natural nutraceuticals and engineered body-management products. The categories of demand are growing fast: everyday immune and metabolic wellness, and active lifestyle and sports-performance formulations.
Every product moves through a defined development process, from concept through formulation, claim and label review, product record, and manufacturing preparation. The intelligence the platform surfaces is the same discipline Nitches applies to its own products, now made portable for the founders it chooses to work with.
Why This Matters Now
Consumers are increasingly prioritizing health, wellness, fitness, and ingredient transparency. As demand grows for products supported by sound formulation, quality manufacturing, and credible product positioning, supplement founders face greater scrutiny than ever before. The brands that succeed are those that identify risks early and build with clarity from the start. Nitches is developing the infrastructure designed to help founders navigate that process before significant capital is committed.
Official platform details will be announced soon. Stay tuned to the company's social media channels.
Founders, creators, and brands interested in learning more during soft launch can email [email protected] for early details.
About Nitches, Inc.
Nitches, Inc. (OTC: NICH) is a supplement and lifestyle-enhancement company preparing a new product readiness platform that helps founders, brands, and manufacturing partners move from supplement idea to formula, score, product record, and manufacturing readiness.
Investor Relations
John Morgan
Nitches, Inc. (OTC: NICH)
[email protected]
+1 (678) 999-6242
NITCHES, INC.
1333 N Buffalo Dr. Suite 210
Las Vegas, NV 89128
+1 (678) 999-6242
[email protected]
Disclaimer: Platform outputs are informational and do not constitute legal, regulatory, medical, scientific, manufacturing, financial, or investment advice. Dietary supplement products are not FDA-approved. Statements regarding the platform reflect current plans and are subject to change.
Forward-Looking Statements
This communication may contain forward-looking statements within the meaning of applicable securities laws. These statements are based on current expectations, estimates, and projections and involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Nitches, Inc. undertakes no obligation to update or revise any forward-looking statements except as required by law.
SOURCE: Nitches, Inc.
View the original press release on ACCESS Newswire
A.Malone--AMWN